India-made typhoid vaccine efficacy lasts for four years: study Subject: Science and tech Section: Health Context: A phase-3 trial conducted in Malawi on children aged between nine months and 12 years has demonstrated that the “Typbar” typhoid vaccine, developed by Hyderabad-based Bharat Biotech, maintains its efficacy for at least four years. Details: The […]